Asentech Named PM360 Trailblazer Award Finalist for App/Digital Solution Category

NEW YORK CITY, NY / ACCESSWIRE / August 18, 2024 / PM360, a monthly magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries, has named Asentech LLC as an APP/DIGITAL SOLUTION finalist.

The Trailblazer Awards were established in 2009 to recognize and honor achievements in healthcare marketing. All of the award finalists and winners are judged and selected by the PM360 Editorial Advisory Board, comprising some of the most forward-thinking leaders in their respective fields. To reach the finalist phase, Companies must show achievement in various areas including innovation, talent development, and social responsibility.

Asentech’s advanced digital engineering solutions are meticulously designed to cater to the personalized needs of patients, healthcare professionals, and practices. By leveraging its extensive expertise and a deep understanding of regulations such as HIPAA, Hi-tech, and NCPDP, Asentech develops optimized solutions across cross-functional teams.

“We are honored to be recognized by PM360 Trailblazer for our achievements in delivering innovative, customer-first practices. This recognition reflects our commitment to pushing brand marketing beyond traditional reach and awareness goals, to support patients and healthcare professionals with the right tools to drive better health outcomes,” said Anil Bhaskar, Managing Partner of Asentech LLC.

Visit asentechllc.com to learn more about us.

About Asentech

Asentech leads in digital transformation for Life Sciences brands, offering advanced data and technology solutions to amplify customer engagement across multiple channels through data-driven strategies and omnichannel approaches.

Contacts

Rashmi Khairnar
Marketing (rashmi.khairnar@asentech.com)

SOURCE: Asentech

View the original press release on accesswire.com

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

50 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

15 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

18 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

18 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

18 hours ago